RPGRIP1L
Protein fantom
Also known as: CORS3, FTM, FTM_HUMAN, JBTS7, KIAA1005, MKS5, NPHP8, PPP1R134
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q68CZ1
- Gene
- RPGRIP1L
- Ensembl
- ENSG00000103494
- Chromosome
- 16
- Canonical length
- 1315 aa
- Protein class
- Disease related genes, Human disease related genes, Predicted intracellular proteins
- Subcellular location
- Plasma membrane,Basal body,Cytosol
OverviewNCBI Gene
The protein encoded by this gene can localize to the basal body-centrosome complex or to primary cilia and centrosomes in ciliated cells. The encoded protein has been found to interact with nephrocystin-4. Defects in this gene are a cause of Joubert syndrome type 7 (JBTS7) and Meckel syndrome type 5 (MKS5). [provided by RefSeq, Jun 2016]
Canonical amino-acid sequenceUniProt
1315 residues, UniProt reviewed canonical sequence.
>Q68CZ1|RPGRIP1L
1 MSGPTDETAG DLPVKDTGLN LFGMGGLQET STTRTMKSRQ AVSRVSREEL EDRFLRLHDE
61 NILLKQHARK QEDKIKRMAT KLIRLVNDKK RYERVGGGPK RLGRDVEMEE MIEQLQEKVH
121 ELEKQNETLK NRLISAKQQL QTQGYRQTPY NNVQSRINTG RRKANENAGL QECPRKGIKF
181 QDADVAETPH PMFTKYGNSL LEEARGEIRN LENVIQSQRG QIEELEHLAE ILKTQLRRKE
241 NEIELSLLQL REQQATDQRS NIRDNVEMIK LHKQLVEKSN ALSAMEGKFI QLQEKQRTLR
301 ISHDALMANG DELNMQLKEQ RLKCCSLEKQ LHSMKFSERR IEELQDRIND LEKERELLKE
361 NYDKLYDSAF SAAHEEQWKL KEQQLKVQIA QLETALKSDL TDKTEILDRL KTERDQNEKL
421 VQENRELQLQ YLEQKQQLDE LKKRIKLYNQ ENDINADELS EALLLIKAQK EQKNGDLSFL
481 VKVDSEINKD LERSMRELQA THAETVQELE KTRNMLIMQH KINKDYQMEV EAVTRKMENL
541 QQDYELKVEQ YVHLLDIRAA RIHKLEAQLK DIAYGTKQYK FKPEIMPDDS VDEFDETIHL
601 ERGENLFEIH INKVTFSSEV LQASGDKEPV TFCTYAFYDF ELQTTPVVRG LHPEYNFTSQ
661 YLVHVNDLFL QYIQKNTITL EVHQAYSTEY ETIAACQLKF HEILEKSGRI FCTASLIGTK
721 GDIPNFGTVE YWFRLRVPMD QAIRLYRERA KALGYITSNF KGPEHMQSLS QQAPKTAQLS
781 STDSTDGNLN ELHITIRCCN HLQSRASHLQ PHPYVVYKFF DFADHDTAII PSSNDPQFDD
841 HMYFPVPMNM DLDRYLKSES LSFYVFDDSD TQENIYIGKV NVPLISLAHD RCISGIFELT
901 DHQKHPAGTI HVILKWKFAY LPPSGSITTE DLGNFIRSEE PEVVQRLPPA SSVSTLVLAP
961 RPKPRQRLTP VDKKVSFVDI MPHQSDETSP PPEDRKEISP EVEHIPEIEI NMLTVPHVPK
1021 VSQEGSVDEV KENTEKMQQG KDDVSLLSEG QLAEQSLASS EDETEITEDL EPEVEEDMSA
1081 SDSDDCIIPG PISKNIKQSL ALSPGLGCSS AISAHCNFRL PGSSDFPASA SQVDGITGAC
1141 HHTQPSEKIR IEIIALSLND SQVTMDDTIQ RLFVECRFYS LPAEETPVSL PKPKSGQWVY
1201 YNYSNVIYVD KENNKAKRDI LKAILQKQEM PNRSLRFTVV SDPPEDEQDL ECEDIGVAHV
1261 DLADMFQEGR DLIEQNIDVF DARADGEGIG KLRVTVEALH ALQSVYKQYR DDLEALocalizationUniProt · AlphaFold · HPA
Whether an antibody against RPGRIP1L can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.47
- Highest tissue expression
- 13 nTPM
Expression across tissuesHPA
Tissue
- testis: 13 nTPM
- parathyroid gland: 7.2 nTPM
- fallopian tube: 6.3 nTPM
- cerebral cortex: 5.3 nTPM
- pituitary gland: 4.3 nTPM
- thyroid gland: 4.2 nTPM
Single-cell type
- ependymal cells: 271 nCPM
- respiratory ciliated cells: 177 nCPM
- thyrotrophs: 103 nCPM
- somatotrophs: 99 nCPM
- choroid plexus epithelial cells: 98 nCPM
- lactotrophs: 95 nCPM
Immune cell
- naive CD8 T-cell: 1.8 nTPM
- naive B-cell: 1.5 nTPM
- gdT-cell: 1.2 nTPM
- MAIT T-cell: 1.2 nTPM
- memory B-cell: 1.1 nTPM
- memory CD8 T-cell: 1 nTPM
Brain region
- choroid plexus: 31 nTPM
- cerebral cortex: 21 nTPM
- hypothalamus: 17 nTPM
- midbrain: 17 nTPM
- white matter: 16 nTPM
- medulla oblongata: 16 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about RPGRIP1L.
Disease | AllUniProt
Conditions RPGRIP1L is implicated in, by any mechanism.
- Joubert syndrome 7 (JBTS7) MIM:611560
- Meckel syndrome 5 (MKS5) MIM:611561
- COACH syndrome 3 (COACH3) MIM:619113
Disease | GeneticClinVar
336 pathogenic / likely-pathogenic of 2,131 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Joubert syndrome
- Meckel-Gruber syndrome
- Joubert syndrome 7
- Meckel syndrome, type 5
- COACH syndrome 3
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.96
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.11
- DepMap mean gene effect
- 0.08
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 4% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- cerebellum development
- cochlea development
- corpus callosum development
- determination of left/right symmetry
- embryonic forelimb morphogenesis
- embryonic hindlimb morphogenesis
- establishment of planar polarity
- establishment or maintenance of cell polarity
- in utero embryonic development
- kidney development
- lateral ventricle development
- liver development
- negative regulation of G protein-coupled receptor signaling pathway
- neural tube patterning
- non-motile cilium assembly
- nose development
- olfactory bulb development
- pericardium development
- regulation of smoothened signaling pathway
- retinal rod cell development
Molecular functions
- thromboxane A2 receptor binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RPGRIP1L in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RPGRIP1L as an antibody target. Whether an autoantibody or antibody against RPGRIP1L could matter depends on whether native RPGRIP1L is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RPGRIP1L is annotated at the cell surface, where native RPGRIP1L is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label RPGRIP1L as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...